Glyset and Levaquin drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among 6 people who take Glyset and Levaquin. Common interactions include electrocardiogram qt prolonged among females, and electrocardiogram qt prolonged among males.

The phase IV clinical study analyzes what interactions people who take Glyset and Levaquin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

6 people who take Glyset and Levaquin together, and have interactions are studied.

What is Glyset?

Glyset has active ingredients of miglitol. Currently, eHealthMe is studying from 355 Glyset users.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is used in sinusitis. Currently, eHealthMe is studying from 56,103 Levaquin users.

Number of Glyset and Levaquin reports submitted per year:

Glyset and Levaquin drug interactions.

Common Glyset and Levaquin drug interactions by gender *:


  1. Electrocardiogram qt prolonged


  1. Electrocardiogram qt prolonged
  2. Abdominal discomfort
  3. Asthenia
  4. Atelectasis
  5. Azotaemia
  6. Balance disorder
  7. Cardiac failure congestive
  8. Cardiac murmur
  9. Cardiovascular disorder
  10. Cardiovascular insufficiency

Common Glyset and Levaquin drug interactions by age *:
















  1. Abdominal discomfort
  2. Abscess
  3. Atelectasis
  4. Azotaemia
  5. Balance disorder
  6. Cardiac failure congestive
  7. Cardiac murmur
  8. Cardiovascular disorder
  9. Cardiovascular insufficiency
  10. Cellulitis

* Approximation only. Some reports may have incomplete information.

Do you take Glyset and Levaquin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Browse interactions between Glyset and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levaquin drug interactions:

Browse interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on miglitol and levofloxacin (the active ingredients of Glyset and Levaquin, respectively), and Glyset and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Glyset and Levaquin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: